TRADING UPDATES: BioPharma Credit sees third year of consistent returns
Tue, 16th Mar 2021 15:35
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
BioPharma Credit PLC - Exeter-based life sciences debt investment trust - Says net asset value per shares rises 1.8% to USD1.0217 at December 31 from USD1.0037 a year prior. Pays dividends of 8.29 US cents per share in 2020, comfortably ahead of the target to distribute at least 7 cents per share , and has recently declared a special dividend of 0.29 cents. Says it remains clear that the senior secured loans that form the majority of the company s portfolio continue to be one of the most attractive financing options for the life sciences sector . 2020 was the company s third full year of operations, marking the third year of consistent returns and targets met , according to Chair Harry Hyman.
KRM22 PLC hails significant reduction in losses despite challenging 2020
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
KRM22 PLC enters 2021 stronger than ever
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
KRM22 present full year results, emerging with a springboard for growth in 2021
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.